In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

Explore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access ...

Leena Tewari, chairperson of USV, made headlines with the purchase of luxury apartments in Mumbai for ₹639 crore, India's ...

Altimmune nears a key MASH trial readout, with strong market potential and new liver and alcohol studies supporting growth.

Novo Nordisk's early lead in weight-loss drugs fades as Eli Lilly surges ahead with more effective therapies and faster ...

The number of illegal or fake weight loss drugs seized by the medicines watchdog this month is almost five times that seized ...

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

The FDA has been cut off from producing compounded weight-loss drugs such as Ozempic, Mounjaro or Wegovy, the most effective ...

MEDVi, an online hub for GLP-1 drugs, wants you to know that it's "serious" about helping you lose weight. According to its ...

IND submission planned for mid-2025 with Phase 1 SAD data anticipated by year end BGE-102 induced weight loss in preclinical obesity models, both as monotherapy and in combination with GLP-1 receptor ...

An urgent warning has been issued to the public about an increase in fraudulent websites and ads promoting illegal medicines ...